We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
Cap. Flow
+$77.2M
Cap. Flow %
0.8%
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$53.4M
2
OXY icon
Occidental Petroleum
OXY
+$38M
3
COF icon
Capital One
COF
+$36.7M
4
ELV icon
Elevance Health
ELV
+$27.1M
5
KR icon
Kroger
KR
+$20.2M

Top Sells

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$43.2M
2
MSFT icon
Microsoft
MSFT
+$36.6M
3
QCOM icon
Qualcomm
QCOM
+$34.8M
4
MA icon
Mastercard
MA
+$33.6M
5
MRK icon
Merck
MRK
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Healthcare 14.84%
3 Consumer Discretionary 14.57%
4 Financials 13.21%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCE icon
1101
1st Source
SRCE
$2.17B
-14,809
Closed -$527K
SRPT icon
1102
Sarepta Therapeutics
SRPT
$1.64B
-2,943
Closed -$472K
SSB icon
1103
SouthState Bank Corp
SSB
$10.3B
-4,547
Closed -$217K
STGW icon
1104
Stagwell
STGW
$2B
-57,232
Closed -$119K
TACT icon
1105
Transact Technologies
TACT
$50.5M
-27,700
Closed -$127K
TCX icon
1106
Tucows
TCX
$104M
-12,574
Closed -$721K
TGTX icon
1107
TG Therapeutics
TGTX
$8.19B
-23,900
Closed -$466K
TPST icon
1108
Tempest Therapeutics
TPST
$14.3M
-1,033
Closed -$355K
USFD icon
1109
US Foods
USFD
$22.5B
-227,101
Closed -$4.48M
UVSP icon
1110
Univest Financial
UVSP
$1.23B
-14,097
Closed -$228K
WEX icon
1111
WEX
WEX
$6.42B
-3,754
Closed -$619K
WLY icon
1112
John Wiley & Sons Class A
WLY
$2.83B
-125,513
Closed -$4.89M
WOR icon
1113
Worthington Enterprises
WOR
$2.74B
-31,762
Closed -$730K
XHR
1114
Xenia Hotels & Resorts
XHR
$2.01B
-68,148
Closed -$636K
XNCR icon
1115
Xencor
XNCR
$1.45B
-7,457
Closed -$242K
ZION icon
1116
Zions Bancorporation
ZION
$10.1B
-6,606
Closed -$225K
INVX
1117
Innovex International
INVX
$1.8B
-14,750
Closed -$439K
PRSU
1118
Pursuit Attractions and Hospitality Inc
PRSU
$1.45B
-10,945
Closed -$208K
ITCI
1119
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-12,256
Closed -$315K
CUTR
1120
DELISTED
Cutera, Inc.
CUTR
-14,734
Closed -$179K
LL
1121
DELISTED
LL Flooring Holdings, Inc.
LL
-23,754
Closed -$329K
BCEL
1122
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-9,702
Closed -$206K
CHS
1123
DELISTED
Chicos FAS, Inc.
CHS
-16,126
Closed -$22K
CORR
1124
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-123,332
Closed -$1.13M
RVLP
1125
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-14,250
Closed -$96K

Similar funds

Jacobs Levy Equity Management's Q3 2020 Portfolio in Review

As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
  • Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
  • Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
  • Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
  • Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
  • Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.